Sex differences in clinical response to olanzapine compared with haloperidol

Psychiatry Research

Volumn 110, Issue 1, 2002, Pages 27-37

  Goldstein, Jill M ^a,b,f   Cohen, Lee S ^b   Horton, Nicholas J ^c   Lee, Hang ^b   Andersen, Scott ^d   Tohen, Mauricio ^d,e   Crawford, Ann Marie K ^d   Tollefson, Gary ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e MCLEAN HOSPITAL   (United States)

^f HARVARD UNIVERSITY   (United States)

Author keywords

Haloperidol; Olanzapine; Schizophrenia; Sex; Treatment response

Indexed keywords

HALOPERIDOL; OLANZAPINE;

ADULT; ARTICLE; CHRONICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG RESPONSE; FEMALE; GENDER; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; TREATMENT OUTCOME;

EID: 0037093906     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00028-8     Document Type: Article

References (52)

1. Gender differences in schizophrenia: Rehospitalization and community survival
2. Gender and the course of schizophrenia: Differences in treated outcomes
3. A sex comparison of serotonin immunoreactivity and content in the ferret preoptic area/anterior hypothalamus
4. Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: Sex differences and effects of sex steroids
5. Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia
6. Androgen binding and metabolism in the cerebral cortex of the developing rhesus monkey
7. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data
8. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations
9. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors
10. Sex steroid control of mood, mental state and memory
11. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia
12. Sampling biases in studies on gender and schizophrenia: A reply
13. Gender and the expression of schizophrenia
14. Are there sex differences in neuropsychological functions among patients with schizophrenia?
15. Normal sexual dimorphism of the adult human brain assessed by in-vivo magnetic resonance imaging
16. Drug and family therapy in the aftercare of acute schizophrenics
17. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging
18. An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia
19. Variation in symptom severity over the menstrual cycle of schizophrenics
20. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates
21. Treatment response and gender in patients with schizophrenia and schizoaffective disorder
22. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography
23. Differential olanzapine plasma concentrations by sex in a fixed-dose study
24. A clinical trial of the effects of estrogen in acutely psychotic women
25. Estrogen - A potential treatment for schizophrenia
26. Random-effects models for longitudinal data
27. Gender and schizophrenia
28. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
29. Estrogen formation in the mammalian brain: Possible role of aromatase in sexual differentiation of the hippocampus and neocortex
30. Gonadal steroid influences on brain development and sexual differentiation
31. Gender differences in affective, schizoaffective, and schizophrenic disorders
32. The mechanism of action of novel antipsychotic drugs
33. Developmental expression of estrogen receptor mRNA in the rat cerebral cortex: A nonisotopic in situ hybridization histochemistry study
34. Sex differences in human brain morphometry and metabolism: An in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging
35. The Flinders Sensitive Line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17b-estradiol
36. The Brief Psychiatric Rating Scale
37. Atlas of estradiol-concentrating cells in the central nervous system of the female rat
38. Lack of gender differences in neuroleptic response in patients with schizophrenia
39. Potent anitdopaminergic activity of estradiol at the pituitary level on prolactin release
40. Can estradiol modulate schizophrenic symptomatology?
41. Gender and the use of neuroleptics in schizophrenia: Further testing of the oestrogen hypothesis
42. Olanzapine versus haloperidol treatment in first episode psychosis
43. The role of estrogens in schizophrenia gender differences
44. Interaction of sex, age and neuroleptic dose
45. Gender differences in treatment response in schizophrenia
46. 2A receptors in cerebral cortex and nucleus acumbens in the female rat
47. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients
48. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics
49. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
50. Sampling biases in studies of gender and schizophrenia
51. Gender differences in pharmokinetics and pharmacodynamics of psychotropic medication
52. The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements